Comparison

Residipok vs Nausea & Vomiting Tracker

Price, ratings, monetisation and update history for both apps, side by side β€” with what reviewers say about each.

Head to head
About

Residipok

Features
Read full description

Residipok is a pocket reference for licensed healthcare professionals, trainees, and medical students of accredited health-professions programs. TWO MODULES (v0.4) β€’ MIC Lookup Choose a bacterium and an antibiotic to see the EUCAST v16.0 (2026) Clinical Breakpoint thresholds β€” S, I, R bands by clinical context (systemic, meningitis, urinary, high-dose). Enter an MIC value to categorise it. Special states clearly labelled when no breakpoint is published or the organism is intrinsically resistant. Built especially for pan-resistance scenarios where every threshold matters. β€’ ESC Guideline Reference Structured Class / Level of Evidence summaries of recent ESC cardiology guidelines, covering acute coronary syndromes, heart failure, atrial fibrillation, hypertension, endocarditis, cardiomyopathies, valvular disease, pulmonary hypertension and embolism, peripheral arterial disease, dyslipidaemia, prevention, pregnancy, syncope, supraventricular tachycardia, and more. Each recommendation card links back to the original guideline on escardio.org. IMPORTANT β€” REFERENCE ONLY β€’ Residipok is NOT a medical device. β€’ It does NOT diagnose, treat, cure, or prevent disease. β€’ It is NOT a substitute for clinical judgement or for the original published guideline / breakpoint table. β€’ Always verify against the current EUCAST table and the latest ESC document before clinical reporting. Requires confirmation of HCP / trainee status on first launch. Sign-in by email, Apple, or Google. Sources: EUCAST Clinical Breakpoint Tables v16.0 (2026); European Society of Cardiology Clinical Practice Guidelines (2018–2024).

About

Nausea & Vomiting Tracker

Features
Read full description

Nausea & Vomiting OS is a clinician-built logging app for chronic nausea and vomiting, including cyclic vomiting syndrome (CVS) and cannabinoid hyperemesis syndrome (CHS). Built by a practicing gastroenterologist, it captures the symptom patterns and clinical anchors that make a gastroenterology visit useful. What you log: β€’ Nausea and vomiting episodes β€” frequency and duration β€’ Cyclic pattern (CVS) and cannabinoid use (CHS) β€’ Triggers and what brings relief (including hot-water bathing) β€’ Hydration and weight What you get: β€’ Today’s note: written from your answers, with a plan you can read line by line and the reason behind each line β€’ Episode burden tracked over time β€’ For your next visit: what you recorded and the questions worth asking your gastroenterologist, on one page β€’ Premium: a one-page visit report for your doctor, symptom trends and CSV export β€’ A library on ACG-aligned nausea/vomiting evaluation, CVS guidance, and CHS recognition Privacy by design: β€’ All data stays on your device. No accounts. No cloud sync. β€’ No analytics. No ads. No data sale. About the developer: Nausea & Vomiting OS is built by a board-certified gastroenterologist. The app is decision-support β€” it does not diagnose, treat, or replace clinical care. Bring your data to your gastroenterologist. Premium: 14-day free trial, then a monthly or yearly subscription; the price for your country is shown before you subscribe. Premium can be shared with your family through Family Sharing. Subscriptions auto-renew; cancel anytime in App Store settings. Restore Purchases is available in the app and in Settings. Terms of Use (EULA): https://www.apple.com/legal/internet-services/itunes/dev/stdeula/

Screenshots

Residipok2 screens
Nausea & Vomiting Tracker4 screens

Verdict

The call

The clearest difference is in-app purchases: Residipok at none against Nausea & Vomiting Tracker's 2. Residipok also leads on update cadence (every 2 weeks vs every 3 months). Nausea & Vomiting Tracker's advantage is ads (none vs shown). On price, device support and iOS requirement there is nothing between them.

Scored on Price Β· Rating Β· Positive reviews Β· Number of ratings Β· Update frequency Β· Ads Β· In-app purchases Β· Monetization Β· Best chart rank Β· Devices Β· Requires iOS

CostPrice Β· In-app purchases Β· Ads Β· Monetization

Both are free to download. Nausea & Vomiting Tracker sells 2 in-app purchases, starting at $4.99 per month. Residipok asks for nothing beyond the download.

UpkeepUpdate frequency

Residipok ships an update every 2 weeks, Nausea & Vomiting Tracker every 3 months. Both last shipped on October 25, 2026.

Scorecard3 real differences Β· 3 level
Residipok versus Nausea & Vomiting Tracker: the parameters behind the verdict, then further details
ParameterResidipokNausea & Vomiting Tracker
PriceFreeFree
Update frequencyEvery 2 weeks β€” betterEvery 3 months
AdsYesNo β€” better
In-app purchasesNo β€” betterYes
DevicesiPhone, iPad, iPodiPhone, iPad, iPod
Requires iOS15.115.0 β€” better
Further details β€” not scored
Size111 MB8 MB
Age rating17+17+
DeveloperMaytham Al-taanMuddusir Ayaz

In-app purchases

None

Residipok

No in-app purchases

2 purchases

Nausea & Vomiting Tracker

Subscriptions2
  • Nausea & Vomiting OS Monthly14 Days trial$4.991 Month
  • Nausea & Vomiting OS Annual14 Days trial$29.991 Year

Questions

Is Residipok free?
Residipok is free to download, with no in-app purchases.
Is Nausea & Vomiting Tracker free?
Nausea & Vomiting Tracker is free to download, with in-app purchases available.
Do Residipok or Nausea & Vomiting Tracker have ads?
Residipok shows ads; Nausea & Vomiting Tracker does not.
Which is updated more often, Residipok or Nausea & Vomiting Tracker?
Residipok ships an update every 2 weeks, and Nausea & Vomiting Tracker every 3 months. Most recently, Residipok was updated on October 25, 2026 and Nausea & Vomiting Tracker on October 25, 2026.

Other comparisons